International Myeloma Foundation, Los Angeles, CA Videos

Videos by International Myeloma Foundation in Los Angeles. Founded in 1990, the International Myeloma Foundation is the first and largest myeloma organization.

In the world of cancer, we want to find a way to intervene early on—in #myeloma, that's the stage of smoldering multiple myeloma (SMM). Dr. Joseph Mikhael, IMF Chief Medical Officer, discusses the groundbreaking research presented at #ASH24, on the AQUILA trial.

Other International Myeloma Foundation videos

In the world of cancer, we want to find a way to intervene early on—in #myeloma, that's the stage of smoldering multiple myeloma (SMM). Dr. Joseph Mikhael, IMF Chief Medical Officer, discusses the groundbreaking research presented at #ASH24, on the AQUILA trial.

A Bold Vision for the Future of Myeloma Care and Support
Yelak Biru, IMF President, CEO, & 28-year myeloma patient, shares his vision for the IMF’s integrated approach for the future. Discover innovative technology like our AI #myeloma chatbot or clinical trial finder that can help you on your journey today. https://www.myeloma.org/node/11497 #HelloMyelo #IMF35

IMF President and CEO, and 28-year myeloma patient Yelak Biru shares his vision for the future in honor of the IMF's 35th anniversary.
IMF President and CEO, and 28-year myeloma patient Yelak Biru shares his vision for the future in honor of the IMF's 35th anniversary this year. Our mission is unwavering. Watch the full video to find out more. https://www.myeloma.org/node/11497 #IMF35

What have patients benefited from in maintaining their career and their role as they're experiencing cancer treatment?
What have patients benefited from in maintaining their career and their role as they're experiencing cancer treatment? Sherrie Guerrero, IMF Senior Director of Human Resources, talks about it with Dr. Joseph Mikhael, the IMF's Chief Medical Officer, in this quick clip.

If you're a myeloma patient who's not able to work, there may be other sources of income support.
If you're a #myeloma patient who's not able to work full-time or at all, there may be other sources of income support for you. Sherrie Guerrero, IMF Senior Director of Human Resources, talks about it with Dr. Joseph Mikhael, the IMF's Chief Medical Officer, in this short clip.

What happens when your medical leave for cancer treatment is up but you're not ready to come back?
What happens when your medical leave for cancer treatment is up but you're not ready to come back? Sherrie Guerrero, Senior Director of Human Resources at the IMF, breaks it down in this conversation with Dr. Joseph Mikhael, the IMF's Chief Medical Officer.

Do you have to disclose your myeloma diagnosis to your employer? Sherrie Guerrero, Senior Director of Human Resources at the IMF, breaks it down in this conversation with the IMF's Chief Medical Officer, Dr. Joseph Mikhael.

Will you lose your job if you miss time at work for your cancer treatment?
Will you lose your job if you miss time at work for your cancer treatment? There are protections in place in your workplace—Senior Director of Human Resources at the IMF Sherrie Guerrero breaks it down & explains the FMLA (Family Medical Leave Act).

Cancer and Careers: Essential Worker Protection Tips for Myeloma Patients & Care Partners. Watch the video: https://mmsm.link/3CddGE2

Patient-centric research — how can researchers help improve myeloma patients' quality of life?
Patient-centric research — how can researchers help improve myeloma patients' quality of life? Dr. Joseph Mikhael, Chief Medical Officer of the International Myeloma Foundation, explains the strides being made in patient-centric research at #ASH24. #IMFASH24

"Updates from ASH 2024: Late Relapse Dr. Joseph Mikhael, Chief Medical Officer of the International Myeloma Foundation, dives into the findings of the #ASH24 meeting. #IMFASH24"

Dr. Joseph Mikhael, Chief Medical Officer of the International Myeloma Foundation, explains the top 5 areas of research from #ASH24.
Frontline therapy updates from ASH 2024! Dr. Joseph Mikhael, Chief Medical Officer of the International Myeloma Foundation, explains the top 5 areas of research from #ASH24. #IMFASH24